162 related articles for article (PubMed ID: 15603246)
1. Review of recent US cost estimates of revascularization.
Nagle PC; Smith AW
Am J Manag Care; 2004 Oct; 10(11 Suppl):S370-6. PubMed ID: 15603246
[TBL] [Abstract][Full Text] [Related]
2. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
3. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
Gray DT; Veenstra DL
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):618-24. PubMed ID: 12658204
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
5. Comparing performance between coronary intervention centres requires detailed case-mix adjusted analysis.
Denvir MA; Lee AJ; Rysdale J; Prescott RJ; Eteiba H; Walker A; Starkey IR; Pell JP
J Public Health (Oxf); 2004 Jun; 26(2):177-84. PubMed ID: 15284323
[TBL] [Abstract][Full Text] [Related]
6. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of minimally invasive cardiac operations.
Ferraris VA; Ferraris SP
Heart Surg Forum; 2001; 4 Suppl 1():S30-4. PubMed ID: 11178305
[TBL] [Abstract][Full Text] [Related]
11. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
Odell A; Landelius P; Astrom-Olsson K; Grip L
Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
[TBL] [Abstract][Full Text] [Related]
13. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
Chino M; Sakamoto M; Sasaki T; Isshiki T
J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
[TBL] [Abstract][Full Text] [Related]
14. Costs of payment in Thai acute coronary syndrome patients.
Moleerergpoom W; Kanjanavanit R; Jintapakorn W; Sritara P
J Med Assoc Thai; 2007 Oct; 90 Suppl 1():21-31. PubMed ID: 18431883
[TBL] [Abstract][Full Text] [Related]
15. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
Favarato D; Hueb W; Gersh BJ; Soares PR; Cesar LA; da Luz PL; Oliveira SA; Ramires JA;
Circulation; 2003 Sep; 108 Suppl 1():II21-3. PubMed ID: 12970202
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
[TBL] [Abstract][Full Text] [Related]
17. Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery.
Hlatky MA; Lipscomb J; Nelson C; Califf RM; Pryor D; Wallace AG; Mark DB
Circulation; 1990 Nov; 82(5 Suppl):IV208-13. PubMed ID: 2225406
[TBL] [Abstract][Full Text] [Related]
18. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW
Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241
[TBL] [Abstract][Full Text] [Related]
19. Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI).
Yock CA; Boothroyd DB; Owens DK; Winston C; Hlatky MA
Am Heart J; 2000 Oct; 140(4):556-64. PubMed ID: 11011328
[TBL] [Abstract][Full Text] [Related]
20. Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease.
Wang X; Rokoss M; Dyub A; Gafni A; Lamy A
J Med Econ; 2008; 11(1):119-34. PubMed ID: 19450114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
